JACQUELYN L. SUMER - Chief Legal Officer at Cullinan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Legal Officer
Issuer Symbol
CGEM on Nasdaq
All Insider Reports
All Insider Reports

JACQUELYN L. SUMER - trading volume in the past year for Cullinan Therapeutics, Inc.

Holdings reported by JACQUELYN L. SUMER for Cullinan Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 128,089 $1,853,447 $14.47 24 Feb 2026 Direct
Stock Option (Right to Buy) 230,000 18 Feb 2026 Direct Common Stock

Transactions reported by JACQUELYN L. SUMER for Cullinan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.